Presentations
Danhof M. and Ploeger B., Implementing receptor theory in PK-PD modeling. PAGE.(2008). [Link to publication]
Ploeger B. and Holford N.H., Are Wash-Out Designs Better than Delayed Start Designs? ACOP.(2008).
Steeg T. v., Strougo A., Ploeger B. and Graaf P. v. d., Assessment of the use of complex baseline models in preclinical safety screening: Application of the van der Pol oscillator model to describe heart rate effects in rats. PAGE.(2008). [Link to publication]
Press R.R., Ploeger B.A., Hartigh J.d., Straaten R.J.H.M.v.d., Pelt J.v., Danhof M., Fijter J.W.d. and Guchelaar H.J., Dose Prediction of Tacrolimus in de novo Kidney Transplant Patients with Population Pharmacokinetic Modelling Including Genetic Polymorphisms. PAGE.(2007). [Link to publication]
Benson N., Snelder N., Ploeger B., Napier C., Sale H. and Graaf P.v.d., Utility of a mixed effects approach to defining target binding rate constants. PAGE.(2007). [Link to publication].
Jongh J.d., Post T., Freijer J., Winter W.d., Danhof M. and Ploeger B., Disease system analysis distinguishing disease status from disease process. PSWC.(2007).
Funaki T., Post T., Maune H. and Drenth H., Population PK/PD analysis of compound X to find appropriate dosage regimen in clinical trial. PAGE. (2007).
Strougo A., Elassais-Schaap J., Greef R.d. and Drenth H., Mechanism-based model of effect of co-administration of exogenous testosterone and progestogens on the hypogonadalaxis in men. PAGE. (2007). [Link to publication]
Post T., Funaki T., Maune H. and Drenth H., Circadian rhythm in pharmacodynamics and its influence on the identification of treatment effects. PAGE.(2007). [Link to publication]
Post T.M., Freijer J.I., Winter W.d., Danhof M. and Ploeger B., Accurate Interpretation of the Visual Predictive Check in order to Evaluate Model Performance. PAGE.(2006). [Link to publication]